期刊论文详细信息
Molecular & Cellular Toxicology
Apoptosis and necroptosis-inducing effects of arctigenin on nasal septum carcinoma RPMI-2650 cells in 2D and 3D culture
article
Lee, Yoon-Jin1  Park, Kwan-Sik1  Baek, Byoung Joon2  Lee, Kyong-Ae3  Lee, Sang-Han1 
[1] Department of Biochemistry, College of Medicine, Soonchunhyang University;Department of Otolaryngology–Head and Neck Surgery, Cheonan Hospital, College of Medicine, Soonchunhyang University;Department Food Science and Nutrition, Soonchunhyang University
关键词: Arctigenin;    Dexamethasone;    Necroptosis;    Apoptosis;    DNA damage;    Oxidative stress;    ATP;   
DOI  :  10.1007/s13273-019-00052-x
来源: Korean Society of Toxicogenomics and Toxicoproteomics
PDF
【 摘 要 】

Backgrounds Arctigenin derived from the seeds of Arctium lappa Linnaeus is known as an anticancer drug candidate by targeting various pathways involved in anticancer therapy. Methods Using 2D monolayer and 3D spheroid culture systems in nasal septum carcinoma RPMI-2650 cells, the effects of arctigenin and dexamethasone on cell viability, ROS levels, ATP level, mitochondrial function, apoptosis and necroptosis were examined. Results The combination treatment of both compounds induced strong cytotoxicity, accompanied by increases of sub-G0/G1 peak, annexin V-PE-positive cells, and ROS levels, loss of mitochondrial membrane potential, and decrease of cellular ATP content. These changes were observed as simultaneous induction of DNA damage, apoptosis, and necroptosis. A series of changes by arctigenin and dexamethasone were efficiently restored by decreasing ROS levels or supplementing ATP. Treatment of 3D spheroids with arctigenin and dexamethasone decreased cell viability in the spheroids, but it was slightly resistant than cells under 2D conditions. In addition, this phenomenon was accompanied by an increase in mediators for both apoptosis and necroptosis. Conclusion Results of this study suggest that the apoptosis and necroptosis-inducing effects of arctigenin are associated with ATP depletion due to oxidative mitochondrial dysfunction.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO202108090001883ZK.pdf 2194KB PDF download
  文献评价指标  
  下载次数:6次 浏览次数:0次